Cargando…
Continuous glucose monitoring can disclose glucose fluctuation in advanced Parkinsonian syndromes
Continuous glucose monitoring (CGM) is a method to examine glucose concentration in subcutaneous interstitial fluid sequentially. CGM can disclose glucose fluctuation (GF), which can be unrecognized in routine blood tests. A limited number of studies suggest advanced Parkinsonian syndromes (PS) is a...
Autor principal: | Todo, Hiroyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PAGEPress Publications, Pavia, Italy
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322050/ https://www.ncbi.nlm.nih.gov/pubmed/30687470 http://dx.doi.org/10.4081/ni.2018.7921 |
Ejemplares similares
-
Fluctuation of blood glucose levels in an infant with an ileostomy on
continuous glucose monitoring: A case report
por: Tomotaki, Seiichi, et al.
Publicado: (2018) -
Glycemic fluctuations caused by COVID-19: Results from continuous glucose monitoring
por: Shen, Yun, et al.
Publicado: (2021) -
Nigral glucose metabolism as a diagnostic marker of neurodegenerative parkinsonian syndromes
por: Schröter, Nils, et al.
Publicado: (2022) -
Continuous glucose monitoring
por: Pandit, Kaushik
Publicado: (2012) -
Relationship between fluctuations in glucose levels measured by continuous glucose monitoring and vascular endothelial dysfunction in type 2 diabetes mellitus
por: Torimoto, Keiichi, et al.
Publicado: (2013)